Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Language
Publication year range
1.
Pathogens ; 13(1)2023 Dec 23.
Article in English | MEDLINE | ID: mdl-38251325

ABSTRACT

Acute diarrheal disease (ADD) caused by rotavirus (RV) contributes significantly to morbidity and mortality in children under five years of age. Currently, there are no specific drugs for the treatment of RV infections. Previously, we reported the anti-rotaviral activity of the protein metabolites derived from Bifidobacterium adolescentis. In this study, our aim was to assess the impact of B. adolescentis-secreted proteins (BaSP), with anti-rotaviral activity on the human intestinal C2BBe1 cell line. We initiated the production of BaSP and subsequently confirmed its anti-rotaviral activity by counting the infectious foci using immunocytochemistry. We then exposed the C2BBe1 cells to various concentrations of BaSP (≤250 µg/mL) for 72 h. Cell viability was assessed using the MTT assay, cell monolayer integrity was monitored through transepithelial electrical resistance (TEER), and cytoskeleton architecture and tight junctions (TJs) were examined using confocal microscopy with F-actin and occludin staining. Finally, we utilized a commercial kit to detect markers of apoptosis and necrosis after 24 h of treatment. The results demonstrated that BaSP does not have adverse effects on C2BBe1 cells. These findings confirm that BaSP inhibits rotavirus infectivity and has the potential to strengthen intestinal defense against viral and bacterial infections via the paracellular route.

2.
Biochimie ; 148: 107-115, 2018 May.
Article in English | MEDLINE | ID: mdl-29555372

ABSTRACT

Bifidobacterium is an important genus of probiotic bacteria colonizing the human gut. These bacteria can uptake oligosaccharides for the fermentative metabolism of hexoses and pentoses, producing lactate, acetate as well as short-chain fatty acids and propionate. These end-products are known to have important effects on human health. ß-glucosidases (EC 3.2.1.21) are pivotal enzymes for the metabolism and homeostasis of Bifidobacterium, since they hydrolyze small and soluble saccharides, typically producing glucose. Here we describe the cloning, expression, biochemical characterization and the first X-ray structure of a GH3 ß-glucosidase from the probiotic bacteria Bifidobacterium adolescentis (BaBgl3). The purified BaBgl3 showed a maximal activity at 45 °C and pH 6.5. Under the optimum conditions, BaBgl3 is highly active on 4-nitrophenyl-ß-d-glucopyranoside (pNPG) and, at a lesser degree, on 4-nitrophenyl-ß-d-xylopyranoside (pNPX, about 32% of the activity observed for pNPG). The 2.4 Šresolution crystal structure of BaBgl3 revealed a three-domain structure composed of a TIM barrel domain, which together with α/ß sandwich domain accommodate the active site and a third C-terminal fibronectin type III (FnIII) domain with unknown function. Modeling of the substrate in the active site indicates that an aspartate interacts with the hydroxyl group of the C6 present in pNPG but absent in pNPX, which explains the substrate preference. Finally, the enzyme is significantly stabilized by glycerol and galactose, resulting in considerable increase in the enzyme activity and its lifetime. The structural and biochemical studies presented here provide a deeper understanding of the molecular mechanisms of complex carbohydrates degradation utilized by probiotic bacteria as well as for the development of new prebiotic oligosaccharides.


Subject(s)
Bifidobacterium adolescentis/enzymology , Probiotics , beta-Glucosidase/chemistry , beta-Glucosidase/metabolism , Crystallography, X-Ray , Models, Molecular , Protein Conformation , Substrate Specificity
3.
Probiotics Antimicrob Proteins ; 10(1): 56-63, 2018 03.
Article in English | MEDLINE | ID: mdl-28432676

ABSTRACT

Rotavirus is the leading worldwide cause of gastroenteritis in children under five years of age. Even though there are some available vaccines to prevent the disease, there are limited strategies for challenging diarrhea induced by rotavirus infection. For this reason, researchers are constantly searching for other approaches to control diarrhea by means of probiotics. In order to demonstrate the ability of some probiotic bacteria to interfere with the in vitro rotavirus infection in MA104 cells, strains of Lactobacillus sp. and Bifidobacterium sp. were tested in MA104 cells before the viral infection. As a preliminary assay, a blocking effect treatment was performed with viable bacteria. In this screening assay, four of initial ten bacteria showed a slight reduction of the viral infection (measured by percentage of infection). L. casei (Lafti L26-DSL), L. fermentum(ATCC 9338), B. adolescentis (DSM 20083), and B. bifidum (ATCC 11863) were used in further experiments. Three different treatments were tested in order to evaluate protein-based metabolites obtained from mentioned bacteria: (i) cell exposure to the protein-based metabolites before viral infection, (ii) exposure to protein-based metabolites after viral infection, and (iii) co-incubation of the virus and protein-based metabolites before viral infection to the cell culture. The best effect performed by protein-based metabolites was observed during the co-incubation assay of the virus and protein-based metabolites before adding them into the cell culture. The results showed 25 and 37% of infection in the presence of L. casei and B. adolescentis respectively. These results suggest that the antiviral effect may be occurring directly with the viral particle instead of making a blocking effect of the cellular receptors that are needed for the viral entrance.


Subject(s)
Antiviral Agents/pharmacology , Bifidobacterium adolescentis/physiology , Lacticaseibacillus casei/physiology , Probiotics/pharmacology , Rotavirus Infections/virology , Rotavirus/drug effects , Virus Attachment/drug effects , Cell Line , Gastroenteritis/prevention & control , Gastroenteritis/virology , Humans , Lacticaseibacillus casei/chemistry , Rotavirus/physiology , Rotavirus Infections/prevention & control
4.
J Appl Microbiol ; 120(4): 1041-51, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26801008

ABSTRACT

AIMS: The aim of this study was to determine the antiviral activity of four probiotic metabolites (Lactobacillus and Bifidobacetrium species) against rotavirus in vitro infection monitored by the NSP4 protein production and Ca(2+) release. METHODS AND RESULTS: The antiviral effect of the metabolites was performed due a comparison between a blocking model and an intracelullar model on MA104 cells, with the response of NSP4 production and Ca(2+) liberation measured by flow cytometry. Significant results were obtained with the metabolites of Lactobacillus casei, and Bifidobacterium adolescentis in the reduction of the protein production (P = 0·04 and P = 0·014) and Ca(2+) liberation (P = 0·094 and P = 0·020) in the intracellular model, which suggests a successful antiviral activity against RV infection. CONCLUSIONS: This study demonstrates that probiotic metabolites were able to interfere with the final amount of intracellular NSP4 protein and a successful Ca(2+) regulation, which suggests a new approach to the mechanism exerted by probiotics against the rotavirus infection. SIGNIFICANCE AND IMPACT OF THE STUDY: A novel anti-rotaviral effect exerted by probiotic metabolites monitored by the NSP4 protein during the RV in vitro infection and the effect on the Ca(2+) release is reported; suggesting a reduction on the impact of the infection by decreasing the damage of the cells preventing the electrolyte loss.


Subject(s)
Antiviral Agents/pharmacology , Bifidobacterium adolescentis/metabolism , Glycoproteins/metabolism , Lacticaseibacillus casei/metabolism , Probiotics/pharmacology , Rotavirus/drug effects , Toxins, Biological/metabolism , Viral Nonstructural Proteins/metabolism , Animals , Antiviral Agents/therapeutic use , Cell Line , Macaca mulatta , Probiotics/therapeutic use , Rotavirus/metabolism , Rotavirus Infections/drug therapy , Rotavirus Infections/virology
5.
Article in English | MEDLINE | ID: mdl-23695585

ABSTRACT

Xylose isomerase (EC 5.3.1.5) is a key enzyme in xylose metabolism which is industrially important for the transformation of glucose and xylose into fructose and xylulose, respectively. The Bifidobacterium adolescentis xylA gene (NC_008618.1) encoding xylose isomerase (XI) was cloned and the enzyme was overexpressed in Escherichia coli. Purified recombinant XI was crystallized using the sitting-drop vapour-diffusion method with polyethylene glycol 3350 as the precipitating agent. A complete native data set was collected to 1.7 Šresolution using a synchrotron-radiation source. The crystals belonged to the orthorhombic space group P21212, with unit-cell parameters a = 88.78, b = 123.98, c = 78.63 Å.


Subject(s)
Aldose-Ketose Isomerases/genetics , Aldose-Ketose Isomerases/isolation & purification , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Bifidobacterium/enzymology , Gene Expression Regulation, Bacterial , Aldose-Ketose Isomerases/chemistry , Bacterial Proteins/chemistry , Bifidobacterium/genetics , Crystallization , X-Ray Diffraction
6.
Article in English | VETINDEX | ID: vti-444092

ABSTRACT

The production of antagonistic substance by bacterium present in the infected root canal system (RCS) probably is an important ecological factor for its successful colonization of the local. The objective of this study was to partially characterize an antagonistic substance produced by a Clostridium butyricum isolated from infected RCS.Production of inhibitory compound was evaluated by the agar double layer diffusion technique using Fusobacterium nucleatum and Bifidobacterium adolescentis as indicator bacteria. The physicochemical and biochemical factors tested for the partial characterization were influence of pH and temperature and susceptibility to the action of some proteolytic enzymes. An inhibition zone was observed against the two indicator strains and acidity and bacteriophage were rejected as responsible for this phenomenon. The inhibitory activity showed to be decreasing in a pH range from 3.5 to 6.5 and being stable at temperatures of 60º, 70º and 100ºC, but completely inactivated when exposed at 121ºC. The antagonistic activity was resistant to the proteolytic action of trypsin, a-chymotrypsin and papain. An antagonistic substance was produced by C. butyricum, which was thermo-resistant and probably of non-protein nature.


A produção de substâncias antagonistas por espécies bacterianas presentes em sistema de canais radiculares (SCR) infectados, tem um papel importante na colonização deste sítio. O objetivo deste estudo foi caracterizar parcialmente a substância antagonista produzida por amostra de Clostridium butyricum isolado de SCR infectados.A produção de substância antagonista foi avaliada pela técnica de difusão em ágar utilizando como bactérias indicadoras Fusobacterium nucleatum e Bifidobacterium adolescentis. Os parâmetros físico-químicos utilizados durante a caracterização parcial foram: pH, estabilidade térmica, susceptibilidade à ação das enzimas tripsina, a-quimiotripsina e papaína. Foi observada zona de inibição contra as duas amostras indicadoras e ainda foi demonstrado que ácidos e bacteriófagos não eram responsáveis por este fenômeno. A atividade inibitória mostrou-se diminuída em uma faixa de pH de 3.5 a 6.5 e estável em temperaturas de 60º, 70º e 100ºC, sendo completamente inativada quando exposta a 121ºC. A atividade antagonista foi resistente à ação das enzimas proteolíticas: tripsina, a-quimiotripsina e papaína. A substância antagonista produzida por C. butyricum é termoresistente e provavelmente de natureza não protéica.

SELECTION OF CITATIONS
SEARCH DETAIL